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Abstract
Background The primary aim of this study was to compare the functional outcome of uncemented with cemented total hip 
arthroplasty (THA) for displaced intracapsular hip fractures. The secondary aims were to assess length of surgery, blood 
loss, complications and revision rate between the two groups.
Methods A prospective double-blind randomised control trial was conducted. Fifty patients with an intracapsular hip frac-
ture meeting the inclusion criteria were randomised to either an uncemented (n = 25) or cemented (n = 25) THA. There were 
no differences (p > 0.45) in age, gender, health status or preinjury hip function between the groups. The Oxford hip score 
(OHS), Harris Hip score (HHS), EuroQol 5-dimensional (EQ5D), timed get up-and-go (TUG), pain and patient satisfaction 
were used to assess outcome. These were assessed at 4, 12 and 72 months after surgery, apart from the TUG which as only 
assessed as 6 months.
Results The study was terminated early due to the significantly (n = 8, p = 0.004) higher rate of intraoperative complications 
in the uncemented group: three fractures of the proximal femur and five conversions to a cemented acetabular component. 
There were no significant (p ≥ 0.09) differences in the functional measures (OHS, HSS, EQ5D, TUG and pain) or patient 
satisfaction between the groups. There was no difference in operative time (p = 0.75) or blood loss (p = 0.66) between the 
groups. There were two early revisions prior to 3 months post-operatively in the uncemented group and none in the cemented 
group, but this was not significant (log rank p = 0.16).
Conclusion There was a high rate of intraoperative complications, which may be due to poor bone quality in this patient 
group. There were no ergonomic or functional advantages demonstrated between uncemented and cemented THA. Cemented 
THA should remain as the preferred choice for the treatment of intracapsular hip fractures for patients that meet the criteria 
for this procedure.
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Introduction
Total hip arthroplasty (THA) is an accepted management 
option for displaced intracapsular neck of femur fractures 
for  independent elderly patients [1]. THA relative to a 
hemiarthroplasty for the treatment of displaced intracapsu-
lar neck of femur fractures offers the potential of a better 
post-operative hip specific functional outcome and overall 
generic health but is associated with a higher rate of disloca-
tion and a longer operative time [2, 3]. Cemented THA has 
an increased risk relative to an uncemented THA of bone 
cement implantation syndrome [4], which is associated with 
an increased early and late post-operative mortality rate [5]. 
Therefore uncemented THA has the potential advantage of 
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avoiding cement which is associated with lower rates of car-
diac and respiratory complications and risk of intraoperative 
death [5–9], and a lower post-operative mortality rate rela-
tive to cemented THA [6, 7, 10].
Data from the National Joint Registry found that 29% 
of all THA performed for intracapsular neck of femur frac-
tures were uncemented, whereas 42% were cemented and 
the remainder were hybrid or reverse hybrid fixation [11]. 
Gavaskar et al. [8] found uncemented THA to be associated 
with a shorter operative time, lower blood loss and shorter 
length of stay when compared to cemented THA, however 
this was a non-randomised comparative study consisting of 
only 31 patients in each group. Dogger et al. [12] described 
a cohort of 115 patients undergoing an uncemented THA 
and concluded that uncemented THA offered comparable 
implant survival and complication rates to that of cemented 
THA. Whether there are any functional benefits of an unce-
mented over and a cemented THA for the management of an 
intracapsular neck of femur fracture is not known.
The primary aim of this study was to compare the func-
tional outcome of patients undergoing uncemented with 
cemented THA for a displaced intracapsular hip fractures. 
The secondary aims were to assess length of surgery, blood 
loss, complications and revision rate between uncemented 
with cemented THA for displaced intracapsular hip frac-
tures. The null hypothesis was that there was no clinically 
significant difference in early (12-month) functional out-
come between uncemented with cemented THA for dis-
placed intracapsular hip fractures.
Patients and methods
Study population
The data for this study were obtained prospectively from 
patients recruited to a double-blind randomised controlled 
trial that compared the functional outcome, activity, sat-
isfaction, complications, blood loss, length of surgery for 
patients undergoing uncemented with cemented THA for 
displaced intracapsular hip fractures. During a 16-month 
period (September 2009–December 2010), 50 patients were 
recruited to the study, all of which presented to the study 
centre with their injury. Patient demographics, body mass 
index (BMI), ASA grade were all recorded on admission.
Trial design
The trial was powered to detect a difference of 3.5 points 
in the Oxford hip score (OHS) using the reported stand-
ard deviation of 7.7 [13, 14]. A power calculation (alpha of 
0.05 and beta of 0.8) estimated that 73 patients per group 
would be required, and in addition to allow for a dropout rate 
of 25% at 1 year 100 patients were to be recruited to each 
arm. Ethical approval was granted by the local research eth-
ics committee. Inclusion criteria consisted of: (1) patients 
over the age of 60 years with a displaced intracapsular hip 
fracture and are admitted to the study centre and are under 
the care of four orthopaedic trauma surgeons, (2) patients 
who were independently mobile before their hip fracture, 
(3) patients without cognitive impairment (mini − mental 
score > 6) and able to give informed consent and (4) patients 
without serious concomitant disease. Exclusion criteria 
were: those not meeting the inclusion criteria, patients who 
are not independently mobile outside the home, unable 
to give informed consent and with a serious concomitant 
disease with anaesthetic risk too great for THA will be 
excluded. All patients presented to the trauma unit at the 
study centre and were identified by the consultant in change 
of the patient. Suitable patients were approached at the time 
of admission, approximately 24–48 h prior to surgery, and 
were recruited to the trial through informed consent. Once 
recruited, the senior surgeon allocated the patient to either 
an uncemented or cemented THA. This was drawn at ran-
dom using sealed, numbered envelopes. The patient and 
researcher were blinded to the allocation and remained so 
throughout the trial period.
Functional outcomes, satisfaction and pain 
assessment
Validated patient reported outcome measures were used to 
assess function pre-operatively (OHS only) and post-opera-
tive at 4, 12 and 72 months (for all measures).
The OHS consists of twelve questions assessed on a Lik-
ert scale with values from 0 to 4, a summative score is then 
calculated where 48 is the best possible score (least sympto-
matic) and 0 is the worst possible score (most symptomatic) 
[15].
The Harris hip score (HHS) is a combine subjective and 
objective assessment which contains eight items represent-
ing pain, walking function, activities of daily living, and 
range of motion of the hip joint [16]. The collective score 
ranges from 0 (maximum disability) to 100 (no disability). 
The index consists of subjective questions relating to pain 
and activities of daily living over the previous week and 
objective assessments of hip function and range of motion.
The EuroQoL (EQ) general health questionnaire evalu-
ates five domains (5D,) which include: mobility, self-care, 
usual activities, pain/discomfort and anxiety/depression 
[17]. The 3L version of the EuroQoL questionnaire was 
used, with the responses to the five domains being recorded 
at three levels of severity (no, some/moderate, or unable/
extreme problems). An individual patient’s health state can 
be reported based on a five-digit code for each domain, of 
which there are 243 possible health states. Each health state 
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was converted to a single summary index by applying a 
weighting. These are specific to the United Kingdom (UK) 
population and are based on a time trade-off technique. This 
index is on a scale of − 0.594 to 1, where 1 represents per-
fect health, and negative values represent a state perceived 
as worse than death [18].
Activity outcomes measured
The Timed Up and Go (TUG) test was performed 6 months 
post-operatively as originally described: the patient was 
timed while rising from an arm chair (approximate seat 
height 46 cm), walking at a comfortable and safe pace to a 
line on the floor 3 m away, turn and walk back to the chair 
and sit down again [19]. The patient had a practice walk 
before the assessment to become familiar with the test. A 
faster time indicates a better functional performance [19].
Subjective hip pain was assessed using a visual analogue 
scale from 1 to 10 and was assessed at 4, 12 and 72 months.
Patient satisfaction was assessed at 4, 12 and 72 months 
following surgery by asking four questions with a different 
focus: “Overall how satisfied are you with the results of your 
hip replacement surgery?” The response to each question 
was recorded using a five-point Likert scale: very satisfied, 
somewhat satisfied, neutral, somewhat dissatisfied, and very 
dissatisfied.
Intraoperative measures
The length of surgery was recorded by the theatre nursing 
team and was defined as the time taken from the skin inci-
sion to application of the wound dressing. The blood loss 
was taken as an estimate according to fluids used and the 
overall loss at the end of the case.
Survival
Several endpoints were defined for revision: all cause, 
aseptic loosening, and intension to treat (revision surgery 
performed or offered to patient but refused or the patient 
deemed too frail to undergo revision). Patient mortality 
data were obtained from hospital records and the Scottish 
Office (Communities Analytical Services, Scottish Execu-
tive Justice and Communities) to enable survival analysis 
to be adjusted for those patients who had died during the 
study period.
Surgical procedure and implant
The surgery was performed or supervised by one of seven 
consultant surgeons. The surgical approach was left to the 
surgeon’s discretion. A posterior approach was used in seven 
patients and the rest utilised a direct lateral (Hardinge) 
approach to the hip joint. The cemented group received 
cemented Exeter stem with a contemporary cemented poly-
ethylene cup (Stryker Orthopaedics, Mahwah, New Jersey, 
USA). The uncemented group received an uncemented 
Corail stem and a Pinnacle cup (Depuy, Warsaw, Indiana). A 
standardised rehabilitation protocol was used for all patients, 
with active mobilisation on the first day post-operatively.
Statistical analysis
Data analysis were performed using Statistical Package for 
Social Sciences version 17.0 (SPSS Inc., Chicago, IL, USA). 
A Student’s t test, paired and unpaired, and a Mann–Whit-
ney U test were used to compare scalar variables between 
groups. Dichotomous variables were assessed using a 
Chi square or Fishers exact test if less than n = 5 in a cell. 
Kaplan–Meier methodology was used to investigate implant 
survival [20]. A p value of < 0.05 was defined as significant.
Ethics
Ethical approval was obtained for this study (REC num-
ber: 06/S0501/80) and the project was registered with the 
research and development department and was conducted in 
accordance with the Declaration of Helsinki and the guide-
lines for good clinical practice. The study was retrospec-
tively registered with ClinicalTrials.gov (registration number 
NCT04372966).
Results
There were 76 patients assessed for eligibility during a 
16-month period (September 2009 to December 2010), of 
which 50 were enrolled into the study (Fig. 1). The study 
cohort consisted of 40 female and 10 were male patients 
with a mean age of 74 (range 54–87) years. There were no 
significant differences in gender, age, BMI, ASA grade or 
hip specific preoperative function between the cemented 
and uncemented groups (Table 1). The principal investiga-
tor (JFK) stopped enrolment to the study when only quarter 
of the sample size had been reached (n = 50), due to the fact 
interim analysis demonstrated the incidence of intraopera-
tive (n = 8, p = 0.004 Fishers) and total (relative risk 11.0, 
95% confidence interval 1.5–78.9, p = 0.002 Fishers) rate of 
complications were significantly higher in the uncemented 
group (Table 2).
Primary outcome
There was no significant difference in hip specific func-
tion according to the OHS at 4, 12 or 72 months following 
THA between the groups (Table 3). There was a 5-point 
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greater (better) OHS for the cemented group at 4 months, 
which is clinically significant, but due to the low number 
of patients recruited this was not statistically significant 
(p = 0.11).
Secondary outcomes
There was no significant difference in the HHS, EQ5D, 
TUG or level of pain at 4, 12 or 72 months following THA 
between the groups (Table 3). There was however a trend 
toward better scores for all the outcome measures in the 
cemented group relative to the uncemented group espe-
cially at the 4-month assessment timepoint. There was no 
Fig. 1  CONSORT 2010 flow 
diagram of recruitment and 
follow-up
Analysed  (n=25)
4-month follow-up (n=22)
•Lost to follow up (n=2)
•Died (n=1)
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•Died (n=1)
72-month follow-up (n=15)
•Lost to follow up (n=5)
•Died (n=5)
Allocated to cemented THA group (n=25)
− Received allocated intervention (n=25)
4-month follow-up (n=22)
•Lost to follow up (n=2)
•Died (n=1)
12-month follow-up (n=22)
•Lost to follow up (n=2)
•Died (n=1)
72-month follow-up (n=16)
•Lost to follow up (n=1)
•Died (n=8)
Allocated to uncemented THA group (n=25)
− Received allocated intervention (n=20)
− Did not receive allocated intervention (n=5)
•Converted to cemented cup (n=4)
•Converted to cemented THA (n=1)
Analysed  (n=25)
Allocation
Analysis
Follow-Up
Assessed for eligibility 
(n=69)
Excluded (n=19)
− Met exclusion criteria (n=2)
− Declined to participate (n=8)
− Lost in the screening process (n=7)
− Lived out of area (n=2)
CONSORT 2010 low diagram of recruitment and follow up
Randomised
(n=50)
difference in the rate of satisfaction at 4 (p = 0.71, Fish-
ers), 12 (p = 0.40, Fishers) or 72 (p = 0.29, Fishers) months 
between the two groups. There was no significant difference 
in the Operative time or intraoperative blood loss between 
the groups (Table 4).
Complications
There were eight intraoperative complications, of which 
all were in the uncemented group (Table 2). Of these three 
where minimally displaced proximal femoral fractures man-
aged with cerclage wires and five were due to poor acetabula 
stability and were converted to a cemented socket. There 
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were two revisions, both in uncemented group, one for early 
acetabula migration which was revised to a cemented socket 
and the other for multiple dislocations and deep infection. 
The patient with multiple dislocations and deep infection 
underwent debridement and excision arthroplasty 3 months 
following THA, but due to medical complications died post-
operatively. A further patient with an uncemented THA had 
femoral stem subsidence at 4 months and was noted to have 
Trendelenburg gait but did not want any further surgery. In 
the cemented group there was a death immediately post-
operatively which was thought to be due to cardiac failure, 
he was a 62-year-old male with a past medical history of 
type II diabetes with microvasculopathy and left ventricular 
systolic dysfunction.
Survival
Thirteen patients died during the follow-up period (median 
6.2 years). There were two revisions in the uncemented 
group (92% survival), that were due to early complications 
described above, and none in the cemented group (Fig. 2), 
but this was not significant (log rank p = 0.16).
Discussion
This randomised trial has shown the rate of complications to 
be higher in patients undergoing uncemented compared with 
cemented THA for displaced intracapsular fractured neck 
of femur. There were no differences in hip-specific func-
tion, overall general health or patient satisfaction between 
the uncemented and cemented THA groups. There was no 
observed benefit of the uncemented THA in operative time 
or blood loss when compared to the cemented THA. There 
were two early (less than 3 months) revisions in the unce-
mented THA groups and no revisions in the cemented THA 
group but this was not significant.
Table 1  Patient demographics 
and pre-operative hip function 
(OHS) according to group
*Unpaired Students t test unless otherwise stated, **Chi-square test
Demographic Descriptive Group Difference/ 
odds ratio
(95% CI)
p-value*
Cemented
(n = 25)
Uncemented
(n = 25)
Age (years: mean, SD) 73.3 (7.4) 74.7 (7.4) 1.4 (− 2.8–5.7) 0.94
Sex (n, % of group) Male 5 (20) 5 (20) 1.0 (0.25–4.0) 0.99
Female 20 (80) 20 (80)
BMI (Kg/M2: mean, SD) 26.4 (5.5) 27.5 (7.7) 1.1 (− 1.7–2.6) 0.78
ASA
(n, % of group)
I 3 (12) 4 (16) N/A 0.90**
II 20 (80) 19 (76)
III 2 (8) 2 (8)
IV 0 0
V 0 0
OHS (mean, SD) 43.2 (6.5) 41.5 (9.6) 1.7 (− 2.9–6.4) 0.46
Table 2  Significant adverse 
events after enrolment to the 
study for the first 12 months 
after THA
Study id Brief description Group Time from surgery
002 Conversion to cemented cup Uncemented Intraoperative
016 Revised to cemented cup Uncemented 2 days
017 Multiple dislocations and deep infection Uncemented First at 15 days
018 Conversion to cemented cup Uncemented Intraoperative
019 Stem subsidence Uncemented 4 months
022 Conversion to cemented cup Uncemented Intraoperative
024 Conversion to cemented cup and stem Uncemented Intraoperative
027 Fractured femur Uncemented Intraoperative
042 Fractured femur Uncemented Intraoperative
047 Conversion to cemented cup Uncemented Intraoperative
048 Death—myocardial infarction Cement 8 h
050 Fractured femur Uncemented Intraoperative
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The main limitation of this study was the small number 
of patients assessed due to the decision to stop recruiting 
because of the high complication rate in the uncemented 
THA group. This resulted in the study being underpowered 
to the primary outcome measure, being the OHS, and post 
hoc analysis found the power to be only 35%. The strength 
to the current study is the design, being the only randomised 
controlled trial that the authors are aware of, comparing 
uncemented with cemented THA in patients with displaced 
intracapsular hip fractures. Despite being underpowered to 
show a hip specific functional difference between the groups 
this study has shown the complication rates of uncemented 
THA to be significantly higher than cemented THA and this 
may be more clinically relevant to a patient’s outcome.
The primary aim of this study was to assess whether there 
was any functional benefit of uncemented over cemented 
fixation of THA for patients with a displaced intracapsu-
lar fractured neck of femur. There was a trend towards a 
clinically, being greater than the minimal clinical important 
difference of five points [21], better OHS at 4 months in 
the cemented THA group but this was not statistically sig-
nificant. This may be a type II error in view of the limited 
number of patients recruited. Liu et al. [22] compared the 
functional outcome of patients undergoing an uncemented 
with a cemented stem as part of a THA for patients with an 
intracapsular hip fracture. They found a significantly better 
hip specific function according to the HHS in those undergo-
ing a cemented stem at a minimum of 5-year follow-up. In 
Table 3  Functional measures 
post-operatively according to 
group
Score
(mean, SD)
Timepoint n Cemented Uncemented Difference
(95% CI)
p-value
OHS 4 months 22/22 31.6 (10.9) 26.4 (8.8) 5.2
(− 1.3–11.7)
0.11
12 months 22/24 41.0 (7.0) 40 (10.4) 1.0
(− 4.3–6.3)
0.76
72 months 15/16 37.0 (15.4) 37.5 (12.3) 0.5
(− 11.0–12.0)
0.94
HSS 4 months 22/22 62.3 (7.1) 56.9 (10.5) 5.4
(− 1.0–11.7)
0.09
12 months 22/24 63.6 (7.6) 65.5 (11.8) 1.9
(− 4.6–8.4)
0.55
72 months 15/16 61.9 (11.2) 62.0 (12.0) 0.1
(− 9.1–9.2)
0.99
EQ5D 4 months 22/22 0.80 (0.21) 0.77 (0.13) 0.03
(− 0.09–0.15)
0.60
12 months 22/24 0.85 (0.18) 0.82 (0.25) 0.03
(− 0.12–0.17)
0.72
72 months 15/16 0.79 (0.44) 0.65 (0.43) 0.14
(− 0.27–0.55)
0.49
TUG 6 months 15/16 11.5 (4.8) 12.8 (4.9) 1.4
(− 2.2–4.9)
0.44
Pain 4 months 22/22 0.8 (1.3) 1.3 (1.5) 0.5
(− 0.5–1.5)
0.32
12 months 22/24 0.8 (1.1) 0.8 (1.3) 0.05
(− 0.7–0.83)
0.89
72 months 15/16 1.2 (1.2) 1.3 (1.3) 0.1
(− 0.9–1.0)
0.87
Table 4  Functional measures 
post-operatively according to 
group
Score Cemented (n = 25) Uncemented (n = 25) Difference (95% CI) p-value
Operative time 
(minutes, mean; 
SD)
72.9 (18.4) 75.0 (20.7) 2.1 (− 11.1–15.4) 0.75
Intraoperative 
blood loss (ml, 
mean; SD)
358 (188) 333 (189) 25 (− 88–137) 0.66
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contrast Gavaskar et al. [8] did not find a difference in the 
HSS between patients undergoing an uncemented with those 
undergoing a cemented THA performed for hip fracture at 
a mean follow-up of 3 years, but their study only included 
51 patients in total.
One of the potential advantages of the uncemented rela-
tive to cemented THA is a shorter operative time and lower 
volume of blood loss [7, 8, 23], but this was not observed in 
the current study. This may be due to the increased rate of 
intraoperative complications in the uncemented THA group, 
with five procedures being converted to a cemented cup and 
three proximal femoral fractures were incurred requiring cer-
clage wire fixation, which would have increased the opera-
tive time and blood loss. The 10-min shorter operative time 
associated with an uncemented, compared to a cemented, 
primary THA for osteoarthritis was not be recognised in the 
current study for patients with an intracapsular hip fracture 
[7, 23]. However, if this were the case it seems unlikely such 
a small difference would contribute to a significant improve-
ment in post-operative outcomes for this patient group.
The rate of complications in the current study for unce-
mented THA are consistent with other authors comparing 
the uncemented with cemented stem fixation for THA and 
for hemiarthroplasty for patients with an intracapsular hip 
fracture [6, 24, 25]. In addition the current study has as 
also highlighted the difficulty of uncemented acetabula 
fixation with five intraoperative conversions to cemented 
fixation and early revision of an uncemented acetabula 
component because of loss of position. Chammout et al. 
[6] performed a randomised controlled trial of uncemented 
versus cemented stem fixation as part of a THA for patients 
with an intracapsular hip fracture. They also had to stop 
their trial early, with only a half of patients recruited, due 
to the significantly increased rate of complications in the 
uncemented group. Similar to the current study Chammout 
et al. [6] described three intraoperative femoral fractures, 
three dislocations and one unstable stem, which led them 
to conclude not to recommend uncemented femoral stems 
for THA in hip fracture patients.
The current study demonstrated a 92% and a 100% 
survival rate of the uncemented and cemented THA at 
6 years, respectively. Data from the National Joint Registry 
demonstrated the risk of revision of uncemented relative a 
cemented THA for an intracapsular hip fracture was sig-
nificantly increased (hazard ratio 1.8) when adjusting for 
confounding variables [11]. This supports the findings of 
the current study which also showed a lower survivorship 
for uncemented THA and there seems to be no survivor-
ship benefit over a cemented THA.
Conclusion
There was a high rate of complications in patients under-
going an uncemented compared to cemented THA for their 
displaced intracapsular neck of femur fracture, which may 
be due to poor bone quality in this patient group. There 
were no ergonomic or functional advantages demonstrated 
between uncemented and cemented THA. Cemented THA 
should remain as the preferred choice for the treatment of 
displaced intracapsular hip fractures for patients that meet 
the criteria for this procedure.
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